The increasing prevalence of cancer and the growing demand for minimally invasive diagnostic techniques are driving the growth of the Liquid Tumor Biopsy Market. Liquid tumor biopsy is an advanced diagnostic approach that analyzes biomarkers such as circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), and other tumor-derived components from blood or other body fluids. This technology...